The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Charles Schwab Investment Management Inc. boosted its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – ...

DevOps and CSV form a powerful duo that, with strategic implementation, promises to propel the pharmaceutical industry.

We recently published a list of Paul Singer’s Latest Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company that focuses on the development and commercialization of a new molecular synthetic ...

An update from ASKA Pharmaceutical Holdings Co., Ltd. ( ($JP:4886) ) is now available. ASKA Pharmaceutical Holdings Co., Ltd. has been recognized ...